Mark S. Blumenkranz

Companies

• Annexon, Inc.Board member Aug 12, 2026 to now¹
• Kala Pharmaceuticals (United States)Board member Nov 17, 2021 to Jun 12, 2024²
• IVERIC bioBoard member Jul 17, 2020 to Jul 13, 2023³
• 1Life Healthcare IncBoard member Jan 30, 2020 to Feb 24, 2023⁴
• Avalanche BiotechnologiesBoard member Jul 30, 2014 to Feb 17, 2016⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKala Pharmaceuticals (United States) KALA14,367 shares⁶$2.8K at $0.19Jun 12, 2024
• 1H1Life Healthcare Inc0 shares⁷Feb 22, 2023
• IBIVERIC bio0 shares⁸Jul 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2024Granted 1,400 shares of Kala Pharmaceuticals (United States)⁶
• Jul 11, 2023Returned to company 32,088 shares of IVERIC bio⁸
• Jun 22, 2023Granted 1,100 shares of Kala Pharmaceuticals (United States)⁹
• Jun 22, 2023Granted 3,784 shares of Kala Pharmaceuticals (United States)⁹
• May 31, 2023Granted 1,640 shares of Kala Pharmaceuticals (United States)¹⁰
• May 11, 2023Exercised options 14,588 shares of IVERIC bio¹¹
• Mar 10, 2023Granted 497 shares of Kala Pharmaceuticals (United States)¹⁰
• Mar 10, 2023Granted 65,634 shares of Kala Pharmaceuticals (United States)¹⁰
• Mar 10, 2023Granted 2,013 shares of Kala Pharmaceuticals (United States)¹⁰
• Feb 22, 2023Returned to company 4,534 shares at $18.00 of 1Life Healthcare Inc⁷
• Feb 15, 2023Other 2 shares of Kala Pharmaceuticals (United States)¹⁰
• Feb 15, 2023Other 68 shares of Kala Pharmaceuticals (United States)¹⁰
• Feb 15, 2023Other 3 shares of Kala Pharmaceuticals (United States)¹⁰
• Jul 15, 2022Exercised options 5,000 shares of IVERIC bio¹²
• Jun 2, 2022Exercised options 4,534 shares of 1Life Healthcare Inc¹³
• May 11, 2022Exercised options 7,500 shares of IVERIC bio¹⁴
• Nov 15, 2021Granted 38,965 shares of Kala Pharmaceuticals (United States)¹⁵
• Nov 15, 2021Granted 5,144,390 shares of Kala Pharmaceuticals (United States)¹⁵
• Nov 15, 2021Granted 157,765 shares of Kala Pharmaceuticals (United States)¹⁵